Metformin hydrochloride extended-release tablets belong to the class of hypoglycemic agents of the biguanide class, which mainly lower blood sugar by reducing hepatic glucose output and improving peripheral insulin resistance. The action and efficacy of Metformin Hydrochloride Extended-Release Tablets is mainly to lower blood glucose. Metformin hydrochloride extended-release tablets are the first-line medication recommended by various clinical guidelines for patients with type 2 diabetes, and are preferred regardless of body type. Metformin Hydrochloride Extended-Release Tablets can prevent the development of diabetes. Metformin Hydrochloride Extended-Release Tablets can effectively reduce the risk of developing type 2 diabetes in people with prediabetes. Metformin hydrochloride extended-release tablets have the feature of reducing the number of doses, taking 1 time a day is 0.5g or 2 times a day, which can maintain a smooth and effective blood concentration. The advantage of metformin extended-release tablets compared with ordinary tablets is that the drug will not be released all at once after eating through the production of extended-release, and some patients have gastrointestinal reactions to metformin, the reaction will be reduced. After taking the drug will appear nausea, vomiting, abdominal distension, switching to extended-release tablets will not have this feeling. Generally slow-release tablets are recommended to be taken after meals, and the exact amount to be taken in a day should be determined according to the specialist’s advice. If the blood sugar is not too high, you can take it 1-2 times a day after meals, generally you can take it at once. Metformin extended-release tablets, because metformin hydrochloride extended-release tablets are prescription drugs, mainly for type 2 diabetes mellitus that is not treated with simple diet control and physical exercise, especially for patients with type 2 diabetes mellitus with obesity. Metformin can also be used in combination with insulin to reduce insulin dosage and prevent the occurrence of hypoglycemia, and can also be used in combination with sulfonylurea hypoglycemic drugs to have a coordinated effect. Metformin hydrochloride extended-release tablets can be used for gynecological polycystic ovary syndrome. Metformin is anecdotally said to be used for weight loss. Although it has the function of weight loss, Metformin Hydrochloride Extended-Release Tablets is also a prescription drug and can produce many adverse reactions. The occurrence of hypoglycemic adverse reactions is relatively rare under ordinary circumstances, but there are some special circumstances in which hypoglycemic reactions can occur, so the public is not allowed to choose it as a weight loss drug to take on its own. Metformin is excreted in urine as a prototype and is not metabolized by the liver, nor is it re-excreted by the bile. It is recommended to be taken orally, with dinner, and needs to be swallowed whole, not chewed. The dose for adults is usually 1 time a day, 2 tablets once is 0.5g, later the dosage will be adjusted according to blood sugar and urine sugar, the maximum daily dose should not exceed 8 tablets 2g, if 1 time a day, 8 tablets 2g each time, can not achieve satisfactory efficacy, can be changed to 2 times a day, 4 tablets 1g each time.